Literature DB >> 6377897

Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies.

W W Hancock, R C Atkins.   

Abstract

The relative contributions of glomerular epithelial cells, macrophages, and other cell types to the formation of cellular crescents characteristic of human rapidly progressive glomerulonephritis remain controversial. To identify and quantitate the cell types present during different stages of glomerular crescent formation, immunoperoxidase labelling of cryostat sections from renal biopsies with cellular (n = 9) or sclerosed (n = 3) crescents was performed using monoclonal antibodies to cell-specific antigens of leucocytes, epithelial cells, and other glomerular cell types. Fresh cellular crescents consisted of macrophages (34.5 +/- 7.0%; mean +/- SEM) plus lesser proportions of polymorphs (12.8 +/- 4.7%) and epithelial cells (10.4 +/- 1.5%). Sclerosed crescents contained fewer macrophages (5.1 +/- 1.0%), but similar proportions of polymorphs (11.1 +/- 2.9%) and epithelial cells (11.5 +/- 2.1%). Lymphocytes were not detected within crescents. Many of the remaining unlabelled cells morphologically resembled fibroblasts and expressed surface fibronectin, though fibroblast-specific cell markers were not available. These results show that macrophages and not epithelial cells constitute the major cell type within cellular crescents. Therapeutic manoeuvres directed against macrophages may, therefore, be of clinical value in the management of human crescentic rapidly progressive glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377897     DOI: 10.1159/000166800

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  15 in total

Review 1.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

2.  Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells.

Authors:  A B Magil
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

3.  Immunohistochemical demonstration of parietal epithelial cells and macrophages in human proliferative extra-capillary lesions.

Authors:  C Guettier; D Nochy; C Jacquot; C Mandet; J P Camilleri; J Bariety
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 4.  Inflammatory processes in renal fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

Review 5.  Update on crescentic glomerulonephritis.

Authors:  Carole Hénique; Christina Papista; Léa Guyonnet; Olivia Lenoir; Pierre-Louis Tharaux
Journal:  Semin Immunopathol       Date:  2014-06-20       Impact factor: 9.623

6.  Conditional ablation of macrophages halts progression of crescentic glomerulonephritis.

Authors:  Jeremy S Duffield; Peter G Tipping; Tiina Kipari; Jean-François Cailhier; Spike Clay; Richard Lang; Joseph V Bonventre; Jeremy Hughes
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

7.  Excretion of epidermal growth factor-like material in acute Henoch-Schönlein purpura nephritis.

Authors:  P R Goodyer; J Fata; C G Goodyer
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 8.  Adhesion molecules in glomerulonephritis.

Authors:  D J Nikolic-Paterson; I W Main; H Y Lan; P A Hill; R C Atkins
Journal:  Springer Semin Immunopathol       Date:  1994

9.  Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis.

Authors:  H Y Lan; D J Nikolic-Paterson; W Mu; R C Atkins
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Effects of tumour necrosis factor alpha and interleukin 1 beta on the proliferation of cultured glomerular epithelial cells.

Authors:  M Yanagisawa; H Imai; Y Fukushima; T Yasuda; A B Miura; Y Nakamoto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.